APA (7th ed.) Citation

Rose, P., Java, J., Morgan, M., Secord, A., Kesterson, J., Stehman, F., . . . Copeland, L. (2016). Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology, 141, 207. https://doi.org/10.1016/j.ygyno.2016.04.534

Chicago Style (17th ed.) Citation

Rose, P.G, et al. "Disease Extent at Secondary Cytoreductive Surgery Is Predictive of Progression-free and Overall Survival: An NRG Oncology/Gynecologic Oncology Group Study." Gynecologic Oncology 141 (2016): 207. https://doi.org/10.1016/j.ygyno.2016.04.534.

MLA (9th ed.) Citation

Rose, P.G, et al. "Disease Extent at Secondary Cytoreductive Surgery Is Predictive of Progression-free and Overall Survival: An NRG Oncology/Gynecologic Oncology Group Study." Gynecologic Oncology, vol. 141, 2016, p. 207, https://doi.org/10.1016/j.ygyno.2016.04.534.